期刊文献+

318株医院感染金黄色葡萄球菌的调查及耐药性分析

下载PDF
导出
摘要 目的了解金黄色葡萄球菌的临床分布特点和耐药性,为临床抗感染治疗提供依据。方法对2011年该院患者标本中分离的318株金黄色葡萄球菌进行标本分布、科室分布、耐药性等统计分析。结果318株金黄色葡萄球菌主要分离自痰液、脓液等标本,科室分布以神经内、外科和ICU科及呼吸内科为主,MRSA的检出率为48.4%。未检出替考拉宁和万古霉素耐药的菌株,耐药率较低的抗菌药物为复方新若明和利福平,耐药性较高的抗菌药物依次为青霉素G、苯唑西林、红霉素。MRsA的耐药率均显著高于MSSA。结论金黄色葡萄球菌耐药严重,特别是对MRSA应引起临床的重视,其临床分布广、耐药性强,临床应根据药敏试验的结果合理使用抗菌药物。
作者 刘凤芹
出处 《检验医学与临床》 CAS 2013年第A02期98-99,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献4

  • 1吴凡.美国HICPAC医疗保健机构多药耐药菌管理指南(2006)[J].中华医院感染学杂志,2008,18(4). 被引量:16
  • 2Boak LM, Li J, Rayner CR, et al. Pharmacokmetic/ptlar- macodynamic factors influencing emergence of resistance to linezolid in an in vitro model[J]. Antimicrob Agents Chemother, 2007,51 (4) : 1287-1292.
  • 3Meka VG, Pillai SK, Sakoulas G, et al. Linezolid resistance in sequential Staphylococcus aureus isolates associated- with a T2500A mutation in the 23S rRNA gene and lossof a single copyof rRNA[J]. J Infect Dis, 2004,190 (2) : 311 - 317.
  • 4汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2008年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2009,9(5):321-329. 被引量:422

二级参考文献12

  • 1王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 2Clinical and I.aboratory Standards Institute(CLSI). Perform ance standards for Antimicrobial susceptibility testing[S]. M100-S17, 2007.
  • 3Clinical and Laboratory Standards Institute (CLSI). Perform anee standards for Antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 4Bratu S, I.andman D, Haag R, et al. Rapid spread of carbapenem resistant Klebsiella pneumoniae in New York City: anew threat to our antibiotic armamentarium[J]. Arch Int Meal.2005,165(12) :1430-1435.
  • 5Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA [J]. J Antimierob Chemother, 2009, 63(3):427-437.
  • 6Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenem resistant Acinetobacter baumannii producing the OXA- 23 β- lactamase in Korea[J]. J Clin Microbiol, 2005, 43(5):2241 -2245.
  • 7NaasT, LevyM, HirschauerC, et al. Outbreak ofcarbapen em resistant Acinetobacter baumannii producing the carbap enemase OXA- 23 in a tertiary care hospital of Pepcete, French Polynesta[J]. J Clin Mierohiol, 2005, 43 (9) : 4826- 4829.
  • 8Waites KB, Dully LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and invitro activity of tigecycline, a new glycylcycline antimicrobial[J]. Antimicrob Agents Chemother, 2006,50(10):3479- 3484.
  • 9Souli M, Kontopidou FV, Koratzanis E, et al. lnvitro activity of tigecycline against multiple-drug resistant, including pan resistant, Gram negative and Gram-positive clinical isolates from Greek hospitals[J]. Antimicrob Agents Chemother, 2006.50(9) :3166- 3169.
  • 10Gordon NC, Warehan, DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline [J]. J Antimicrob Chemother, 2009, 63(4) :775-780.

共引文献436

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部